Ogorek Anthony Joseph’s ResMed RMD Stock Holding History

Ogorek Anthony Joseph’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	2	–	–	﹤0.01%	685
2026 Q1	$0	Hold	2	–	–	﹤0.01%	693
2025 Q4	$0	Sell	2 -1	-33%	-$256	﹤0.01%	687
2025 Q3	$0	Buy	3 +1	+50%	+$273	﹤0.01%	680
2025 Q2	$0	Hold	2	–	–	﹤0.01%	681
2025 Q1	$0	Buy	+2	New	+$467	﹤0.01%	667

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ogorek Anthony Joseph's RMD Position: Q2 2026 in Review

Ogorek Anthony Joseph held its ResMed (RMD) position steady in Q2 2026 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Ogorek Anthony Joseph first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Ogorek Anthony Joseph held 2 shares of ResMed worth $0 as of Q2 2026.
Ogorek Anthony Joseph left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #685 holding.
Ogorek Anthony Joseph first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.